Mostrar el registro sencillo del ítem

Amphetamine derivatives as monoamine oxidase inhibitors

dc.contributor.authorReyes-Parada M.
dc.contributor.authorIturriaga-Vasquez P.
dc.contributor.authorCassels B.K.
dc.date.accessioned2020-09-02T22:26:59Z
dc.date.available2020-09-02T22:26:59Z
dc.date.issued2020
dc.identifier10.3389/fphar.2019.01590
dc.identifier.citation10, , -
dc.identifier.issn16639812
dc.identifier.urihttps://hdl.handle.net/20.500.12728/6012
dc.descriptionAmphetamine and its derivatives exhibit a wide range of pharmacological activities, including psychostimulant, hallucinogenic, entactogenic, anorectic, or antidepressant effects. The mechanisms of action underlying these effects are usually related to the ability of the different amphetamines to interact with diverse monoamine transporters or receptors. Moreover, many of these compounds are also potent and selective monoamine oxidase inhibitors. In the present work, we review how structural modifications on the aromatic ring, the amino group and/or the aliphatic side chain of the parent scaffold, modulate the enzyme inhibitory properties of hundreds of amphetamine derivatives. Furthermore, we discuss how monoamine oxidase inhibition might influence the pharmacology of these compounds. © 2020 Royal Society of Chemistry. All rights reserved.
dc.language.isoen
dc.publisherFrontiers Media S.A.
dc.subjectAmphetamine derivatives
dc.subjectDopamine transporter
dc.subjectMonoamine oxidase
dc.subjectMonoamine oxidase-A
dc.subjectNorepinephrine transporter
dc.subjectSerotonin syndrome
dc.subjectSerotonin transporter
dc.subject2,6 dichloro 4 dimethylaminoamphetamine
dc.subject4 iodo 2,5 dimethoxyamphetamine
dc.subjectaliphatic compound
dc.subjectamiflamine
dc.subjectamine oxidase (flavin containing)
dc.subjectamino acid derivative
dc.subjectamphetamine derivative
dc.subjectaromatic compound
dc.subjectcathinone
dc.subjectfenfluramine
dc.subjectfla 289
dc.subjectfla 314
dc.subjectfla 384
dc.subjectfla 405
dc.subjectfla 450
dc.subjectfla 463
dc.subjectfla 558
dc.subjectfla 717
dc.subjectfla 727
dc.subjectfla 788
dc.subjectmethamphetamine
dc.subjectmonoamine oxidase A inhibitor
dc.subjectmonoamine oxidase B inhibitor
dc.subjectmonoamine oxidase inhibitor
dc.subjectphenethylamine
dc.subjectphentermine
dc.subjectserotonin receptor
dc.subjectunclassified drug
dc.subjectantidepressant activity
dc.subjectArticle
dc.subjectbinding affinity
dc.subjectchemical modification
dc.subjectdrug binding site
dc.subjectdrug identification
dc.subjectdrug potency
dc.subjectdrug receptor binding
dc.subjectdrug targeting
dc.subjectenantioselectivity
dc.subjectenzyme inhibition
dc.subjecthuman
dc.subjectmolecular docking
dc.subjectnonhuman
dc.subjectstructure activity relation
dc.subjectstructure analysis
dc.subjecttranquilizing activity
dc.titleAmphetamine derivatives as monoamine oxidase inhibitors
dc.typeArticle


Ficheros en el ítem

Thumbnail
Nombre:
item_2-s2.0-85079171968.pdf
Tamaño:
3.159Kb
Formato:
PDF
Ver/

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem